OncoSpherix expands leadership team with the appointment of Allan Valmonte, M.B.A., as Vice President of Business Operations

by Oncospherix | Apr 28, 2023 | General

April 28, 2023 Allan Valmonte, M.B.A., former Executive Director, Program Management Office (PMO) at Taysha Gene Therapies, joins OncoSpherix with over 25 years of program/portfolio management and clinical operations experience in the biotechnology and pharmaceutical...

OncoSpherix expands leadership team with the appointment of Steve Coats, Ph.D. as Vice President of Chemistry

by Oncospherix | Apr 28, 2023 | General

April 28, 2023 Dr. Steve Coats, former Senior Director of Chemistry at Cocrystal Pharma, joins OncoSpherix with over 25 years of drug discovery and development experience in biotechnology and large pharmaceutical companies. Atlanta, GA – April 28, 2023 – OncoSpherix,...

OncoSpherix to Present Data from its Hypoxia Inducible Factor (HIF) Inhibitor 64B in Uveal Melanoma

by Oncospherix | Apr 12, 2023 | General

April 12, 2023 64B is a small molecule therapeutic that inhibits the function of hypoxia inducible factors (HIFs) 64B given systemically inhibits primary tumor growth and metastases 64B was far superior to either sunitinib or selumetinib at causing a regression in...

OncoSpherix CEO to Serve as Keynote Speaker at 5th Meridian Drug Discovery Conference in Boston on Tuesday, November 8, 2022

by Oncospherix | Nov 3, 2022 | General

The 5th Meridian Drug Discovery Conference will be held at the Embassy Suites by Hilton at Boston Longan Airport on November 7-8, 2022. Dr. Margaret Offermann will present a keynote address entitled “Mechanism Matters: Overcoming Past Failures in Developing HIF...

OncoSpherix’s CEO Will Give Keynote Presentation Entitled “Overcoming Past Challenges in Developing Safe and Effective Small Molecule Hypoxia Inducible Factor (HIF) Inhibitors for Treatment Of Aggressive Cancers” in San Francisco on Thursday, October 27

by Oncospherix | Oct 22, 2022 | General

The Agile Falcon Drug Discovery Strategic Summit will be held at the Grand Hyatt at the San Francisco Airport on October 27-28, 2022. OncoSpherix’s CEO, Dr. Margaret Offermann, will be presenting a keynote address entitled “Overcoming Past Challenges in...

OncoSpherix’s CEO is Keynote Speaker and Moderator at Global Women in STEM Leadership Summit In Atlanta on June 6-7, 2022

by Oncospherix | Jun 4, 2022 | General

The Global Women in STEM Leadership Summit is designed to inspire attendees through sessions tailored specifically for promoting women in STEM. It brings together influential leaders and founders from industry, academia, nonprofit and government to share their...